TEM
Tempus AI, Inc.
There isn't enough reported data to score TEM yet.
TEM Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Under pressure | |
| Unavailable |
TEM's revenue is currently healthy, but its profitability and cash flow are under pressure. There isn't enough data to rate its balance sheet.
TEM PE Valuation
TEM has no meaningful PE right now: it lost money over the past year.
TEM Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect TEM's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
TEM Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q4 2021 | -$3.27 | +$0.78 |
TEM is still losing money, but far less than before: $1.77 per share over the past year, against $4.55 at its worst in mid-2021.
TEM Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $411.5M | +23% |
| Q2 2026 | $382.5M | +22% |
| Q1 2026 | $348.1M | +36% |
| Q4 2025 | $367.2M | +83% |
| Q3 2025 | $334.2M | +85% |
| Q2 2025 | $314.6M | +90% |
| Q1 2025 | $255.7M | +75% |
| Q4 2024 | $200.7M | +36% |
TEM's revenue has grown year over year for 16 quarters in a row: $412M last quarter, up 23% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -14% | +4.4 points |
| Q2 2026 | -20% | -0.2 points |
| Q1 2026 | -24% | +2.5 points |
| Q4 2025 | -17% | +8.5 points |
| Q3 2025 | -18% | +11 points |
| Q2 2025 | -20% | +302 points |
| Q1 2025 | -27% | +9.7 points |
| Q4 2024 | -25% | +10 points |
TEM's operating margin was −14% last quarter, up 4.4 points from the same quarter a year ago, near the top of its range since 2020.
TEM Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$122K | +$126.4M |
| Q2 2026 | -$13.7M | -137% |
| Q1 2026 | -$81.5M | +$26.2M |
| Q4 2025 | -$41.5M | +$5.7M |
| Q3 2025 | -$126.5M | -360% |
| Q1 2025 | -$107.7M | -$212K |
| Q4 2024 | -$47.2M | -$4.2M |
| Q3 2024 | $48.6M | +$117.6M |
TEM has burned cash in almost every quarter: −$137M over the past year, against −$245M the year before.
TEM Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -100% | -170M shares |
| 1 year | -100% | -170M shares |
| 3 years | -100% | -62.7M shares |
TEM has 174,264 diluted shares, down 100% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2024 | — |
| Q3 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
| Q1 2023 | $3.6M |
| Q4 2022 | — |
TEM Net Leverage
TEM's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
TEM Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 57.8 | Neutral |
| Stochastic | 68.0 | Neutral |
TEM's weekly RSI is 58 (neutral) and its Stochastic is 68 (neutral).
TEM PE vs Healthcare Sector
TEM has no meaningful PE right now: it lost money over the past year.
TEM Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $73.6 | 3.1% above |
| 20 week MA | $64.5 | 18% above |
| 50 week MA | $58.9 | 29% above |
| 100 week MA | $61.2 | 24% above |
TEM is in an uptrend: it's above all four of its weekly moving averages, and 24% above its 100-week average.
TEM Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2024 | $40.3 | $35.1 | -13% |
| 2025 | $35.1 | $62.7 | +79% |
| 2026 YTD | $62.7 | $75.9 | +21% |
TEM has finished lower in one of the last two years. It's up 21% so far in 2026.